Literature DB >> 8524587

Is there a need for binocular vision evaluation in low vision?

M M Rundström1, F Eperjesi.   

Abstract

The purpose of this study was to determine the need for a binocular vision evaluation in the management of low vision patients. Thirty subjects were selected with visual acuities of at least 6/60 in each eye. Twenty-three had age-related macular degeneration as the primary ocular pathology and seven had various other ocular conditions. The binocular vision evaluation comprised: detailed history and symptoms with an emphasis on the occurrence of near vision problems; modified binocular vision assessment which included cover test at near, ocular movements, convergence, Bagolini glasses, horizontal vergence reserves and prismatic measurement of any observed anomaly. History and symptoms revealed horizontal and vertical diplopia, jumbling of print, asthenopia, intermittent blurring and print being too small. Binocular vision assessment revealed exophoria at near, manifest horizontal deviations, convergence insufficiency, and vertical muscle imbalance. These anomalies occurred either singly or in combination. The results indicate that there is a need for binocular vision evaluation in low vision in order to reveal near vision disorders that may be partly attributable to binocular vision anomaly and not solely due to ocular pathology. This information should facilitate the implementation of the appropriate course of optometric management for these patients.

Entities:  

Mesh:

Year:  1995        PMID: 8524587

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  2 in total

1.  Residual stereopsis in age-related macular degeneration patients and its impact on vision-related abilities: a pilot study.

Authors:  Kathy Y Cao; Samuel N Markowitz
Journal:  J Optom       Date:  2014-01-24

Review 2.  Topical Review: Assessment of Binocular Sensory Processes in Low Vision.

Authors:  Janelle Tong; Jessie Huang; Vincent Khou; Jodi Martin; Michael Kalloniatis; Angelica Ly
Journal:  Optom Vis Sci       Date:  2021-04-01       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.